Sell IT, buy pharma? What Trump tariffs mean for Indian stock market investors

Pharma stocks surged as Trump’s tariffs spared the sector, while IT stocks fell on U.S. slowdown fears.

Broader markets remained stable despite global sell-offs, with small- and micro-caps dodging volatility.

Higher U.S. tariffs may boost India’s exports but risk shrinking overall demand.

Inflation concerns could delay Fed rate cuts, increasing market uncertainty.